Skip to main content

Advertisement

ADVERTISEMENT

videos

Ray Cross
Video
03/27/2023
Dr Cross, regional chair for the Advances in Inflammatory Bowel Disease, invites you to the in-person regional meeting in Baltimore March 31-April 1 -- and offers a discount on the registration fee!
Dr Cross, regional chair for the Advances in Inflammatory Bowel Disease, invites you to the in-person regional meeting in Baltimore March 31-April 1 -- and offers a discount on the registration fee!
Dr Cross, regional chair for the...
03/27/2023
Advances in Inflammatory Bowel Disease Network
Aline Charabaty
Conference Coverage
03/12/2023
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins...
03/12/2023
Advances in Inflammatory Bowel Disease Network
Parambir Dulai
Video
02/16/2023
Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's...
Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's...
Dr Dulai, from Northwestern...
02/16/2023
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Conference Coverage
02/05/2023
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews the risks of cancer among patients with primary sclerosing cholangitis and inflammatory bowel disease, including bile duct cancer and hepatocellular carcinoma, and how to...
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews the risks of cancer among patients with primary sclerosing cholangitis and inflammatory bowel disease, including bile duct cancer and hepatocellular carcinoma, and how to...
Dr Loftus, from the Mayo Clinic...
02/05/2023
Advances in Inflammatory Bowel Disease Network
Infusion
Conference Coverage
12/31/2022
Drs Regueiro and Siegel review their debate from the Advances in Inflammatory Bowel DIseases 2022 annual meeting about if, when, and how to stop or de-escalate therapy for IBD.
Drs Regueiro and Siegel review their debate from the Advances in Inflammatory Bowel DIseases 2022 annual meeting about if, when, and how to stop or de-escalate therapy for IBD.
Drs Regueiro and Siegel review...
12/31/2022
Advances in Inflammatory Bowel Disease Network
Gil Melmed
Conference Coverage
12/07/2022
Dr Melmed, from Cedars-Sinai in Los Angeles, discusses neurological complications that may arise among patients being treated for inflammatory bowel disease--and what clinicians should watch for to prevent or mitigate them.
Dr Melmed, from Cedars-Sinai in Los Angeles, discusses neurological complications that may arise among patients being treated for inflammatory bowel disease--and what clinicians should watch for to prevent or mitigate them.
Dr Melmed, from Cedars-Sinai in...
12/07/2022
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
12/06/2022
Dr Regueiro, from Cleveland Clinic, reviews the armamentarium of therapies available today for inflammatory bowel diseases and how best to position them to optimize outcomes among patients.
Dr Regueiro, from Cleveland Clinic, reviews the armamentarium of therapies available today for inflammatory bowel diseases and how best to position them to optimize outcomes among patients.
Dr Regueiro, from Cleveland...
12/06/2022
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
12/06/2022
Dr Rubin, from the University of Chicago, explains key points from his presentation at AIBD 2022 on risks of colon cancer among patients with inflammatory bowel disease and how to best monitor for dysplasia and mitigate risks.
Dr Rubin, from the University of Chicago, explains key points from his presentation at AIBD 2022 on risks of colon cancer among patients with inflammatory bowel disease and how to best monitor for dysplasia and mitigate risks.
Dr Rubin, from the University of...
12/06/2022
Advances in Inflammatory Bowel Disease Network
Alan Moss, MD
Conference Coverage
12/06/2022
Dr Moss, from Boston University School of Medicine, discusses his presentation on defining severity of inflammatory bowel disease, including differences in patient and physician perceptions.
Dr Moss, from Boston University School of Medicine, discusses his presentation on defining severity of inflammatory bowel disease, including differences in patient and physician perceptions.
Dr Moss, from Boston University...
12/06/2022
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer
Conference Coverage
12/05/2022
Dr Hanauer, from Northwestern University Feinberg School of Medicine in Chicago, reviews his keynote address at the Advances in Inflammatory Bowel Diseases meeting on how variations in the presentation of IBD provide human models for the...
Dr Hanauer, from Northwestern University Feinberg School of Medicine in Chicago, reviews his keynote address at the Advances in Inflammatory Bowel Diseases meeting on how variations in the presentation of IBD provide human models for the...
Dr Hanauer, from Northwestern...
12/05/2022
Advances in Inflammatory Bowel Disease Network

Advertisement